Status:

ACTIVE_NOT_RECRUITING

Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease

Lead Sponsor:

Hadassah Medical Organization

Collaborating Sponsors:

Rambam Health Care Campus

Tel-Aviv Sourasky Medical Center

Conditions:

Bone Marrow Transplant Complications

Eligibility:

FEMALE

18+ years

Brief Summary

Allogeneic stem cell transplantation (also termed "bone marrow transplantation") involves transferring stem cells from a healthy person (the donor) to the patient, after high-intensity chemotherapy or...

Eligibility Criteria

Inclusion

  • Age≥18
  • Candidate for allogeneic stem cell transplantation
  • Ability to sign an informed consent

Exclusion

  • \- Patient does not approve sample collection

Key Trial Info

Start Date :

February 15 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05316740

Start Date

February 15 2022

End Date

December 1 2026

Last Update

March 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hadassah Medical Center

Jerusalem, Jerusalem, Israel, 9765422

Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease | DecenTrialz